Virus-specific cytotoxic T lymphocytes (CTL) which kill virus-infected cells are thought to be
a major host defence against viral infections 1–11 . Here we report the existence of human …

Widespread antibiotic use in clinical medicine and the livestock industry has contributed to
the global spread of multidrug-resistant (MDR) bacterial pathogens, including Acinetobacter …

We conducted a double-blind, placebo-controlled trial of the efficacy of oral azidothymidine (AZT)
in 282 patients with the acquired immunodeficiency syndrome (AIDS) manifested by …

The chronic Epstein-Barr virus syndrome is a poorly defined symptom complex characterized
primarily by chronic or recurrent debilitating fatigue and various combinations of other …

Objective To evaluate the safety and efficacy of once daily doses of tenofovir DF (TDF)
administered in combination with other antiretroviral therapy (ART) in treatment-experienced HIV-…

Background This double-blind study evaluated treatment with either a single nucleoside or
two nucleosides in adults infected with human immunodeficiency virus type 1 (HIV-1) whose …

We conducted virus-isolation studies on 56 specimens from the nervous system of 45 patients
in order to determine whether human T-cell lymphotropic virus Type III (HTLV-III) is directly …

Objective To update recommendations for antiretroviral therapy for adult human immunodeficiency
virus type 1 (HIV-1) infection, based on new information and drugs that are available. …

Context The availability of new antiretroviral drugs and formulations, including drugs in new
classes, and recent data on treatment choices for antiretroviral-naive and -experienced …

Context Recent data regarding the consequences of untreated human immunodeficiency
virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and …